Higher mortality from non-small cell lung cancer reported in subjects treated with oestrogen and progestin

Higher mortality from non-small cell lung cancer reported in subjects treated with oestrogen and progestin

The Women's Heath Initiative (WHI) trial was a double-blind randomised placebo-controlled trial that examined the health benefits and risks of combined oestrogen and progestin in 16608 postmenopausal women in the USA.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Thorax 2010-03, Vol.65 (3), p.200-200
1. Verfasser: Marsden, P A
Format: Artikel
Sprache:eng
Schlagworte:
Biological and medical sciences
Cardiology. Vascular system
Endocrine therapy
Health risk assessment
Lung cancer
Medical sciences
Not Applicable
Pneumology
Tumors of the respiratory system and mediastinum
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Women's Heath Initiative (WHI) trial was a double-blind randomised placebo-controlled trial that examined the health benefits and risks of combined oestrogen and progestin in 16608 postmenopausal women in the USA.
ISSN:0040-6376
1468-3296
DOI:10.1136/thx.2009.134809